Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine

    • Product Name 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine
    • Alias MolPort-003-904-013
    • Einecs 642-232-4
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    252865

    Product Name 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine
    Molecular Formula C10H19N3O2
    Molecular Weight 213.28 g/mol
    Cas Number 329735-40-8
    Appearance White to off-white solid
    Solubility Soluble in DMSO, methanol
    Purity Typically > 95%
    Storage Condition Store at room temperature, keep dry
    Synonyms N-(4-Morpholinylacetyl)piperazine
    Smiles C1COCCN1CC(=O)N2CCNCC2
    Inchi InChI=1S/C10H19N3O2/c14-10(13-3-1-11-2-4-13)8-12-5-7-15-9-6-12/h11H,1-9H2

    As an accredited 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing A white, sealed 100g bottle labeled "4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine," featuring hazard warnings, lot number, and handling instructions.
    Shipping The shipping of 4-[2-(Piperazin-1-yl)-acetyl]-morpholine complies with all applicable safety and regulatory guidelines. The chemical is securely packaged in sealed containers, labeled with hazard information, and protected against moisture and light. Shipping is conducted via certified carriers, with documentation and tracking provided to ensure safe and timely delivery.
    Storage 4-[2-(Piperazin-1-yl)-Acetyl]-Morpholine should be stored in a tightly sealed container, protected from light, moisture, and incompatible substances. Store at room temperature (15–25°C) in a well-ventilated, dry area. Ensure the container is clearly labeled and placed in a designated chemical storage cabinet, away from strong acids, bases, and oxidizing agents. Always follow local regulations for chemical storage.
    Application of 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine

    Applications of 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine in Industrial Manufacturing

    As the direct manufacturer of 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine, our continuous focus is on supplying high-purity, tightly-specified raw material for advanced industrial syntheses. This compound occupies key positions in the supply chain of several structurally demanding downstream fields, particularly where heterocyclic chemistry determines end product quality. Below, we detail real-world industrial scenarios where this intermediate forms an irreplaceable part of the manufacturing process.

    1. Pharmaceutical Intermediates for Antipsychotic Drugs

    In the active pharmaceutical ingredient (API) industry, 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine plays a critical role as a core intermediate in multi-step syntheses of antipsychotic drugs, notably atypical neuroleptics containing both morpholine and piperazine motifs. Large-scale API producers implement this intermediate during the condensation and cyclization stages when constructing molecular scaffolds associated with active CNS pharmacology. Material specifications focus on single impurity levels and control of residual solvents, as stringent pharmacopoeial standards prohibit any risk of cross-contamination in psychiatric formulations.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for APIs
    • Current Good Manufacturing Practice (cGMP) – 21 CFR Part 210/211
    • EDQM CEP/USP/NF monographs for relevant end APIs
    • Process-specific solvent and impurity thresholds as per EMA and FDA guidelines

    Typical usage ratio

    • Typically 1.05–1.15 molar equivalents related to cyclization substrate, adjusted by stoichiometry of side chain assembly and batch size scaling

    Downstream process integration

    • Introduced during the nucleophilic substitution/conjugation stage, where the morpholine-acetylated fragment completes N-alkylation on heteroaromatic scaffolds under anhydrous conditions, usually in multi-ton batch reactors with strict process analytical technology controls

    Final product types

    • Bulk APIs for second-generation antipsychotics (e.g., quetiapine, olanzapine analogs)
    • Finished psychiatric medications in oral solid dosage forms
    • API intermediates supplied to generic drug manufacturers
    • Research-stage CNS drug candidates using similar heterocyclic scaffolds

    2. Specialty Chemical Building Blocks for Advanced Agrochemicals

    Formulators in the crop protection sector use this compound as a source of a nitrogen-rich moiety in constructing next-generation fungicide and herbicide active ingredients that feature dual morpholine-piperazine fragments for improved systemicity. Downstream manufacturers value its high chemical stability during key steps such as acylation and ring closure, allowing consistent yields during scaled multi-ton syntheses. Documentation includes traceability for all impurity profiles and toxicological screening for regulatory registration.

    Industry compliance standards

    • FAO/WHO Specifications for Agricultural Pesticides
    • ISO 9001:2015 Quality Management for chemical synthesis
    • REACH registration and safety dossier requirements
    • OECD GLP for analytical data in safety assessments

    Typical usage ratio

    • Ranges from 2–8% m/m within stepwise reaction sequences; actual dosage defined by molecular target and crop segment toxicity limits

    Downstream process integration

    • Fed into the core assembly step during heterocyclic cyclization and subsequent functionalization via protected group removal or direct oxidation in custom jacketed reactors with controlled temperature and pH, prior to formulation of active technical concentrate

    Final product types

    • Technical grade fungicide actives (morpholine-piperazine derivatives)
    • Concentrated emulsion and suspension agrochemical formulations
    • Premixed crop protection agents for high-value fruit and vegetable farming
    • Herbicide intermediates for downstream custom synthesis

    3. Contract Manufacturing for Protected API Intermediates in Oncology

    This compound supports the oncology segment as a highly selective reactant in contract manufacturing of protected intermediates for kinase inhibitor APIs. Multi-stage peptide or heterocycle construction often requires introduction of the morpholine-acetyl moiety as an orthogonally protected group, which remains chemically inert through subsequent condensation and deprotection. Contract API facilities document full traceability back to our lot-specific batch records, supporting regulatory dossiers and full lifecycle quality verification for clinical use.

    Industry compliance standards

    • ICH Q11 Development and Manufacture of Drug Substances
    • GMP guidelines for Investigational Medicinal Products (IMP) manufacture
    • EMA and FDA process validation guidance
    • ISO 13485 for medical device-related drug ingredients where relevant

    Typical usage ratio

    • 0.8–1.2 equivalents based on protection group strategy and excess minimization principles for high-value oncology intermediates

    Downstream process integration

    • Supplied as a solid or pre-dissolved phase, joining the reaction sequence at the selective protection or N-acylation step using inert atmosphere autoclaves, followed by purification under cGMP isolation protocols in segregated suites

    Final product types

    • Sterile oncology API intermediates
    • Small molecule kinase inhibitor precursors
    • Oligopeptide conjugates with morpholine-protected sites
    • Clinical trial material for targeted cancer therapeutics

    4. Synthesis of Research-Grade Heterocyclic Reference Standards

    Academic and industrial laboratories engaged in medicinal chemistry or chemical biology rely on this structural intermediate as a well-characterized building block for assembling small molecular libraries and analytical standards. Its incorporation enables fine structure-activity relationship studies for both piperazinyl- and morpholine-containing scaffolds. Our direct supply to R&D customers includes full COA, impurity profile, and stability data for downstream QC validation and GLP research protocols.

    Industry compliance standards

    • ISO/IEC 17025 Laboratory Competence Accreditation
    • OECD Good Laboratory Practice (GLP)
    • Chemical Abstracts Service (CAS) registry and substance tracking
    • ICH Q3A guidelines on residual solvents and impurities for reference materials

    Typical usage ratio

    • Variable: typically 15–30 mmol per analytical batch, with excess dependent on screening library size and synthetic route

    Downstream process integration

    • Used as a substrate during stepwise library synthesis, entered at either initial scaffold assembly or final derivatization, with in-process analytical monitoring for purity and identity using HPLC, GC-MS, or NMR

    Final product types

    • Heterocyclic analytical and reference standards
    • Custom medicinal chemistry compound libraries
    • GLP-compliant screening compounds for pharmaceutical lead discovery
    • Stable isotope-labeled analogs for metabolite profiling
    Free Quote

    Competitive 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine: Practical Insights from the Production Floor

    We have spent years working with piperazine and morpholine derivatives. Among the more valuable compounds in our portfolio, 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine stands out for its unique structure, reliable behavior during synthesis, and the flexibility it lends downstream chemistries. The product itself represents a point where knowledge, safety, and hands-on experience all play a role—qualities earned batch after batch, not just through documentation.

    Product Details Drawn From Daily Practice

    This compound, sometimes referenced as N-(2-Morpholinoacetyl)piperazine, features a molecular formula of C10H19N3O2. We routinely produce crystalline solid batches with tight control on purity, all informed by thousands of lab hours and real-world troubleshooting. Its melt point, stability under storage, and behavior in various solvent systems are not just theoretical—it comes from real tanks, actual flasks, and quality control under pressure.

    Each lot meets high-performance chromatography standards because our staff, from QC all the way to logistics, invest in clear protocols. Tracking impurities at the parts-per-million range guides choice of solvents and filtration strategies. The finished material never leaves our floor until it clears stringent HPLC and NMR benchmarks, based on established spectral libraries and verified in our laboratory sequence every time.

    Particle size, moisture thresholds, and residual solvent content reflect our direct operating experience in reaction handling and downstream workups. No batch goes forward unless it maintains the consistency our own downstream chemists demand. Staff routinely recalibrate equipment and adjust operational windows based on heat transfer, mixing profiles, and the minute-to-minute changes we see at scale, not just in bench-scale documentation.

    Key Chemical Features Observed in Real Production

    The core of this compound features both a morpholine and a piperazine moiety, connected via a stable acetyl linkage. Morpholine rings provide both hydrophilic and lipophilic handle, making the molecule ready for multiple transformations. Piperazine lends a familiar footprint to medicinal chemists looking for flexible building blocks—its nitrogen atoms readily form bonds, making the compound an attractive platform for further modifications.

    During manufacturing, we observe that the piperazine ring accepts alkylations and acylations without the deactivation problems seen in other systems. The morpholine nitrogen resists unwanted side reactions, even if slightly elevated temperature or extended reaction times are required downstream. These traits translate into fewer purification steps and markedly improved yields, which we track across all lots.

    Product stability is tested not just at time of synthesis, but against weeks of benchtop and warehouse storage. We have migrated from older desiccant-based storage to more robust boxed systems, ensuring solid-state stability through typical humidity swings. We sample for degradation products, not just during shelf-life testing, but also after simulated shipping stresses, because product quality depends on conditions faced outside of our warehouse too.

    Practical Applications: What We and Our Partners Do With It

    Our teams manufacture 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine for one purpose: to supply a viable intermediate for complex development pipelines. Project teams in pharmaceuticals, especially those engaged in CNS-active drug research, depend on the piperazine motif to build selective ligands, enzyme inhibitors, and receptor modulators. Staff scientists in these groups value the compound’s clean, consistent reactivity—each morpholine and piperazine unit opens possibilities for tailor-made molecules without the yield risks or byproduct profiles seen in less stable intermediates.

    Academic groups ask for this material when tackling novel bioisosteres or library expansions. Because our product offers predictable reactivity and robust physical stability, students and professors get the repeatability they need for poster sessions and peer-reviewed publication. We’ve seen the impact close at hand—increased hit rates in high-throughput screening and straightforward scale-ups, even when campaigns march quickly from grams to kilograms.

    Companies developing materials and surface modifiers also benefit from the acetyl-morpholine linkage, especially when seeking hydrophilic-lipophilic balance in polymers, coatings, or sensor platforms. End-users construct tailor-fit macromolecules by customizing either the piperazine or the morpholine arm, taking advantage of the stable amide bond we control during every synthesis. Our industrial partners report improved functional group compatibility and high rates of grafting efficiency, both directly related to the reliability of our starting material.

    Production Nuances: What Sets Our Product Apart in the Workshop

    We do not compromise on control from the very first step—starting with raw material qualification and vendor audits for every in-bound shipment. Piperazine and morpholine stock materials must clear both chemical assay and advanced impurity scans (GC-MS and LC-MS) before entering our reactors. Feedstock variability, if ignored, guarantees trouble downstream. Procurement works shoulder-to-shoulder with technical teams, ensuring that batch-to-batch consistency never becomes guesswork.

    Scale-up runs go through rigorous hazard assessments, since piperazine derivatives can present latent risks. We rely on real exothermicity measurements, careful agitation design, and thermal mapping to prevent runaways and localized overheating—based on past learning, not just HAZOP flowcharts. Every run leverages modern distillation and extraction tricks picked up over decades, often diverging from textbook flows to solve specific operational challenges that only show up at larger scales.

    Yield optimization is about gelling experience with careful analytics. Purification steps use crystallization or column chromatography not just “as needed,” but in direct response to impurity tracking during each batch. We never trust a process until it has delivered a dozen or more consistent, high-purity lots. Documentation lives in accessible shared spaces, not hidden in locked cabinets, so that any scientist or shift supervisor knows exactly what to expect and what to watch for at every stage.

    Differences in Quality: Lessons Learned from Direct Feedback and Use

    Over time, we have compared our product to samples from external producers and pilot-scale syntheses. Some competitors boast high assay numbers but falter in stability or color development under shop floor conditions. We have encountered lots with minor color impurities or inconsistent particle size, which may pass standard QC but cause trouble in coupling and scale-up reactions. These issues slow down integration into real projects, especially where precise reactivity is critical.

    Our investment in real-time analytics—inline FTIR, batchwise NMR spot-checks, moisture probes—shows up in the quality of our material. This approach allows us to catch the subtle inconsistencies that traditional batch QC can miss. As scale increases, it’s easy to overlook small degradation, but cumulative feedback from process chemists prevents this. We have baked lessons from those situations into SOPs so that today’s production doesn’t repeat yesterday’s mistakes.

    Customer feedback tells us another story: our batches hold up well during both storage and fast-track syntheses, especially in laboratories where delay means more than lost time. Partners have shared that our version dissolves cleanly and performs as predicted in polar and non-polar solvent systems, even in demanding steps like urea coupling or carbamate formation. This reliability isn’t theoretical—it runs on trust built up by shared troubleshooting, regular follow-ups, and seeing projects through to their endpoints.

    Improvement Through Experience: The Real Process of Refinement

    Process improvement rarely comes from a single dramatic breakthrough. More often, steady progress is made from examining each cycle, every inspection, and every tank cleaning. We have discarded outdated reactor liners when trace contamination reared its head. Glassware sealing methods, feed pump calibration, and even operator rotation patterns affect batch reproducibility, so we monitor and update on-the-ground practices in response to minor deviations before they snowball into larger issues.

    On top of that, reducing solvent use has become a point of pride. Early routes relied on excess solvent for ease, but tighter flash evaporation protocols, anti-solvent crystallizations, and improved batch quenching have cut solvent waste nearly in half. Staff perform in-house recycling and work directly with environmental managers to guarantee compliance goes beyond paperwork. The impact is felt both in operational margins and in greater confidence from partners with strict green chemistry mandates. This is less about PR and more about stewardship for our own plant and the teams who work in it every day.

    Practical Solutions for Industry Demands

    High throughput and short lead times challenge any chemical manufacturer. By refining each stage—raw material vetting, in-line purification, post-synthesis stabilization—we have consistently met escalating volume and regulatory requests. Teams stay ready to handle both rush orders and “just-in-time” supply strategies without sacrificing quality. Real-life supply reliability stems from early collaboration with both procurement and application scientists, long before a purchase order is even cut.

    Our facilities have implemented batch reservation systems and “trigger point” order management, preventing detrimental stock-outs. Instead of shipping every unit as quickly as possible, we coordinate in advance with users to account for upcoming needs. The operations window sometimes runs nights and weekends to match project launches or scale-up requirements, leveraging skilled teams across shifts who are cross-trained and trusted with every step from charge-in to final testing.

    Common challenges often ignored in technical literature—such as caking during transit, decomposition risks under heat, and loss of crystallinity—get direct attention here. Final packaging design includes built-in thermal buffering and moisture indicators attached to every lot. If any deviation appears during transport or storage, partners know exactly what steps to take, supported by clear, experience-based guidance that grows out of regular post-shipment audits and follow-ups.

    Why End Users Come Back: Experience and Trust in Synthesis

    We understand that for every kilo signed off in our QA room, a dozen more experiments rely on that confidence. Chemists and engineers need to trust their starting materials, not just for one reaction, but for the entire downstream sequence. Our repeat customers often run multiple library campaigns or process validations in parallel, and we have adapted to same-day technical queries, last-minute overnight shipments, and after-action reviews when processes encounter snags.

    Support does not stop after delivery. We maintain open lines between production, application support, and process development staff. Constant feedback from the field—whether it's crystallization yield, unexpected side reactions, or questions about reconstitution—feeds into the next cycle of product refinement. We always welcome partners to visit our plant, observe a batch, or audit our production records, and we encourage transparent sharing of both problems and best practices.

    Over years of collaboration, we have learned that project teams searching for scale-up flexibility and cleaner route development often praise our batch-to-batch reproducibility. Some research groups, looking for alternatives to cumbersome synthetic intermediates, now standardize their campaign launches around our version of 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine, simply because setbacks linked to upstream quality start to disappear.

    Looking Ahead: Anticipating Improvement and Growth

    The challenges never stop, especially as regulatory and sustainability standards tighten. Staff actively engage in continuing education—cross-training in analytical instrumentation, attending regulatory workshops, and delving into green chemistry alternatives. We review and upgrade plant practices on a rolling basis, and technological investment in process control allows us to stay ahead of common pitfalls associated with scale and complexity.

    We view each feedback loop—as concise as a one-word lab note or as detailed as a multi-page deviation report—as a chance to improve. Automation and digitization have their place, but in our experience, every new technology must align with direct operational knowledge, or it becomes another layer of noise. The best gains still come from a blend of skilled staff, empowered to solve problems creatively, and robust investment in continuous learning.

    Conclusion: Expertise Forged Through Real Commitment

    Every batch of 4-[2-(Piperazin-1-Yl)-Acetyl]-Morpholine bears the mark of hundreds of hours spent in reaction optimization, quantitative analysis, packaging design, and real-world troubleshooting. Where many products compete on price and claims, we compete on experience, consistency, and a willingness to adapt as requirements change. The difference between a specification sheet and a trusted supply runs on the care and judgment of real people, working each day in the plant and the lab, always seeking a better result for every partner whose project depends on our work.